Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
IVERMECTIN
Cross Vetpharm Group Limited
QP54AA01
IVERMECTIN
10 Mg/Ml
Solution for Injection
LM-Licensed Merchant
Ovine
Ivermectin
Endectoparasiticides
Authorised
2006-05-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ovimectin 10 mg/ml Solution for Injection for Sheep. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE Ivermectin 10 mg/ml For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. Clear, colourless to slightly yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the effective treatment and control of the following species of gastro-intestinal roundworms, lungworms, grubs and lice of sheep: GASTROINTESTINAL ROUNDWORMS (adult and L 4 ): Teladorsagia (_Ostertagia) circumcincta _including inhibited larvae _O. trifurcata_ _Haemonchus contortus _including inhibited larvae _Trichostrongylus axei _(adults) _T. colubriformis _and _T. vitrinus _(adults) _Cooperia curticei_ _Oesophagostomum columbianum_ _O. venulosum _(adults) _Nematodirus filicollis_ _Chabertia ovina_ _Trichuris _ovis (adults). Benzimidazole-resistant strains of _Haemonchus contortus _and _Ostertagia circumcincta _are also controlled. LUNGWORMS: _Dictyocaulus filaria _(adult and L 4 ) _Protostrongylus rufescens _(adults) NASAL BOTS (all larval stages) _Oestrus ovis_ 4.3 CONTRAINDICATIONS HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 30/11/2015_ _CRN 7022356_ _page number: 1_ Do not use in animals with known hypersensitivity to the active ingredient. Do not use by intramuscular or intravenous administration. Do not use in non-lactating dairy sheep within 60 days of lambing. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately results in ineffect Leggi il documento completo